GH1 and cancer: Research performed by our laboratory has demonstrated that GH action upregulates expression of ATP-binding cassette-containing (ABC) transporters in cancer, contributing to heightened resistance to anticancer therapies in both in vitro and in vivo models [20,21,23,24,33].